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Polybrominated diphenyl ethers (PBDEs) have 
been used as flame retardants in a wide range 
of consumer and household goods (Hale et al. 
2003). Their chemical stability allows PBDEs 
to be global environmental contaminants 
(Costa and Giordano 2007; Tseng et al. 2008). 
An alarming increase in PBDE concentrations 
in humans has been reported (Hites 2004; 
Law et al. 2003). Among congeners, 2,2´,4,4´-
tetra-BDE (BDE47), 2,2´,4,4´,5-penta-BDE 
(BDE99), 2,2´,4,4´,6-penta-BDE (BDE100), 
2,2´,4,4´,5,5´-hexa-BDE  (BDE153), 
2,2´,4,4´,5,6-hexa-BDE (BDE154), and 
2,2´,3,3´,4,4´,5,5´,6,6´-deca-BDE (BDE209) 
are predominant in human tissues (Costa 
et al. 2008; Hites 2004). PBDEs and their 
hydroxylated metabolites (OH-PBDEs) have 
been detected in fetal blood and liver, and in 
maternal breast milk and placenta (Daniels 
et al. 2010; Gómara et al. 2007; Schecter et al. 
2003). Furthermore, PBDEs can cross the 
blood–brain barrier to accumu  late in the central   
nervous system (Naert et al. 2007). On the 
whole, the body burden of PBDEs is increas-
ing (Hites 2004; Law et al. 2003; Sjödin et al. 
2004).
PBDEs/OH-PBDEs have been implicated 
in developmental neuro  toxicity. Neonatal 
exposure induces neuro  behavioral changes in 
rodents (Branchi et al. 2003; Eriksson et al. 
2001; Gee and Moser 2008). Such exposure 
also reduces long-term potentiation and post-
synaptic protein levels in the hippocampus 
(Dingemans et al. 2007) and affects intra-
cellular calcium homeo  stasis and induces oxi-
dative stress (Kodavanti and Ward 2005). 
However, mechanisms of PBDE action in 
developing brain are not yet fully understood.
PBDEs/OH-PBDEs are structurally simi-
lar to the thyroid hormones (THs) 3,5,3´,5´- 
tetraiodo-l-thyronine [thyroxine (T4)] and 
3,5,3´-triiodo-l-thyronine [triiodothyronine 
(T3)] (Schriks et al. 2007). Thus, PBDEs may 
act through the TH system (Birnbaum and 
Staskal 2004). TH is critical for normal brain 
develop  ment (Porterfield 2000), and TH 
deficiency during the peri  natal critical period 
causes abnormal brain develop  ment known 
as cretinism in humans (Koibuchi and Chin 
2000; Rabié et al. 1977). Decreased serum 
levels of T4 have been reported after peri  natal 
exposure to various PBDEs in rodents (Costa 
and Giordano 2007; Rice et al. 2007; Zhou 
et al. 2001, 2002). In addition, OH-PBDEs 
have been shown to bind to the human TH 
receptor (TR) (Kitamura et al. 2008; Kojima 
et al. 2009; Li et al. 2010). A recent reporter 
gene assay study showed that BDE206 inhib-
its TR-mediated transcription (Schriks et al. 
2007). These results suggest that PBDEs/
OH-PBDEs may affect TH-regulated sig-
nal transduction pathways at multiple levels. 
However, mechanisms of PBDE/OH-PBDE 
action on TR-mediated transcription have 
not yet been fully clarified.
To study the mechanisms of TH action 
in the developing brain, we have used rodent 
cerebellum as a model system. Because peri-
natal hypo  thyroidism is associated with 
decreased dendrite arborization and synapto-
genesis of Purkinje cells (Nicholson and 
Altman 1972a, 1972b), Purkinje cells are 
considered a good model to examine vari-
ous TH actions in developing brain. Using 
this system, Kimura-Kuroda et al. (2007) 
observed the modification of TH-induced 
dendrite arborization by hydroxylated poly-
chlorinated biphenyls (OH-PCBs). 
The present study was designed to examine   
the mechanisms of PBDE action on modula-
tion of TR-mediated gene expression and 
on morphological alterations in cultured 
Purkinje cells. Because the structure of PBDE 
is similar to that of PCB, we hypothesized 
that PBDE could suppress TR-mediated TH 
action.
Materials and Methods
Chemicals. We purchased T3, T4, and dexa-
methasone (Dex) from Sigma Chemical Co. 
(St. Louis, MO, USA). All PBDE/OH-PBDE 
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ba c K g R O u n d: Polybrominated diphenyl ethers (PBDEs) have been used as flame retardants and 
are becoming a ubiquitous environmental contaminant. Adverse effects in the developing brain are 
of great health concern.
Ob j e c t i v e: We investigated the effect of PBDEs/hydroxylated PBDEs (OH-PBDEs) on thyroid 
hormone (TH) receptor (TR)-mediated transcription and on TH-induced dendrite arborization of 
cerebellar Purkinje cells.
Me t h O d s : We examined the effect of PBDEs/OH-PBDEs on TR action using a transient trans-
fection-based reporter gene assay. TR–cofactor binding was studied by the mammalian two-hybrid 
assay, and TR–DNA [TH response element (TRE)] binding was examined by the liquid chemilumi-
nescent DNA pull-down assay. Chimeric receptors generated from TR and glucocorticoid receptor 
(GR) were used to identify the functional domain of TR responsible for PBDE action. The change 
in dendrite arborization of the Purkinje cell in primary culture of newborn rat cerebellum was also 
examined.
Re s u l t s: Several PBDE congeners suppressed TR-mediated transcription. The magnitude of sup-
pression correlated with that of TR–TRE dissociation. PBDEs suppressed transcription of chimeric 
receptors containing the TR DNA binding domain (TR-DBD). We observed no such suppres-
sion with chimeras containing GR-DBD. In the cerebellar culture, PBDE significantly suppressed 
TH-induced Purkinje cell dendrite arborization.
cO n c l u s i O n s: Several PBDE congeners may disrupt the TH system by partial dissociation of TR 
from TRE acting through TR-DBD and, consequently, may disrupt normal brain development.
Key w O R d s : flame retardants, gene regulation, neurodevelopment, neurogenesis, polybrominated 
diphenyl ethers (PBDEs), thyroid. Environ Health Perspect 119:168–175 (2011).  doi:10.1289/
ehp.1002065 [Online 22 September 2010]PBDE and TH-mediated neuronal development
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congeners were purchased from AccuStandard 
Chemicals (New Haven, CT, USA). Purity 
was > 99% for all PBDE congeners and 
> 98% for all OH-PBDEs. DE-71 contains 
BDE99 (44%), BDE47 (32%), BDE100 
(9%), BDE153 (4%), and other PBDEs (total 
11%). Ethanol (Wako, Osaka, Japan) was 
used as a vehicle. All compounds were com-
pletely dissolved in ethanol at concentrations 
< 10–4 M and stored at –20°C. Dilutions 
were made from stock solutions immediately 
before use, and repeated freezing and thawing 
were avoided. PBDE congeners used in the 
present study were carefully selected to reflect 
their abundance in the environment and in 
humans (Hites 2004; Law et al. 2003).
Plasmids. Expression vectors for TRβ1, 
TRα1, and glucocorticoid receptor (GR) 
were described previously (Iwasaki et al. 
2001, Koibuchi et al. 1999). The luciferase 
(LUC) reporter constructs containing chick 
lysozyme–TH response element (TRE) thy-
midine kinase (TK)-LUC (F2-TRE), arti-
ficial direct repeat TRE–DR4-TK-LUC 
(DR4-TRE), and 2× palindrome (Pal)-
TK-LUC (Pal-TRE) in the PT109 vector 
were described by Koibuchi et al. (1999). A 5× 
upstream activating sequence (UAS)-TK-LUC 
reporter plasmid in the PT109 vector and 
a mouse mammary tumor virus (MMTV) 
promoter containing gluco  corticoid response 
element (GRE), which is fused to the LUC 
promoter (MMTV-LUC), were described by 
Iwasaki et al. (2001). Expression vectors for 
Gal4–DNA binding domain (DBD)-fused 
steroid receptor coactivator-1–nuclear bind-
ing domain-1 (SRC-1–NBD-1; aa 595–780) 
(Takeshita et al. 2002) and VP16-TRβ1–
ligand binding domain (LBD) (Miyazaki 
et al. 2004) were described previously. The 
Gal4 blank, Gal4-SMRT (silencing media-
tor for retinoid and thyroid hormone recep-
tors; aa 1669–2507), and Gal4–N-CoR 
(nuclear receptor corepressor; aa 1579–2454) 
were described previously by Takeshita et al. 
(2002). The gluta  thione S-transferase (GST)-
fused TRβ1 was described by Qiu CH et al. 
(2009). Chimeric receptors were generated 
from TR and GR as described by Miyazaki 
et al. (2008).
Clonal cell culture. CV-1 monkey 
fibroblast-derived cells were maintained in 
Dulbecco’s modified Eagle’s medium sup-
plemented with 10% fetal bovine serum 
deprived of small lipophilic hormone by 
treating with resin and activated charcoal, at 
37°C and 5% CO2.
Transient transfection assay. CV-1 cells 
were plated in 24-well plates 2 days before 
transfection using the calcium phosphate 
coprecipi  ta  tion method (Miyazaki et al. 
2008). The total amount of DNA per well 
was balanced by adding pcDNA3 plas-
mids (Invitrogen, San Diego, CA, USA). 
Cytomegalovirus β-galactosidase plasmid 
was used as an internal control. Sixteen to 
24 hr after transfection, wells were refilled 
with fresh medium containing the indicated 
concentrations of ligand and/or PBDEs and 
incubated for 24 hr. For TH treatment, we 
used T3 because it is bioactive and because 
CV-1 cells do not contain deiodinase activity. 
Cells were then harvested to meas  ure the LUC 
activities as described elsewhere (Miyazaki 
et al. 2008). The LUC activities were normal-
ized to β-galactosidase activity and calculated 
as relative LUC activities. All transfection 
experiments were repeated at least three times 
in triplicate, and data represent mean ± SE of 
one experiment. The method of mammalian 
two-hybrid assay has been described previously 
(Baniahmad et al. 1995; Carey et al. 1989). 
Liquid chemiluminescent DNA pull-down 
assay (LCDPA). The LCDPA was used to 
measure nuclear receptor–DNA binding 
in solution (Iwasaki et al. 2008). Briefly, a 
GST-fused TR (GST-TR) bound to gluta-
thione-Sepharose beads was incubated with a 
digoxigenin (DIG)-labeled double-stranded 
DNA fragment containing a TRE, in 
Figure 1. Congener-specific suppression of TR-mediated transcription by PBDEs/OH-PBDEs. Expression 
plasmids encoding TRβ1 (A–C, E–G) or TRα1 (D; 10 ng) were cotransfected with F2-TRE (A, D–G), 
DR4-TRE (B), or Pal-TRE (C; 100 ng) into CV-1 cells. Cells were incubated with or without 10–7 M T3 and 
indicated amounts of PBDEs/OH-PBDEs. (H) Expression plasmids encoding GR (10 ng) were cotransfected 
with MMTV (GRE)-LUC reporter plasmids (100 ng) into CV-1 cells. Cells were cultured in the absence or 
presence of Dex (10–7 M) and indicated concentrations of BDE209. Total amounts of DNA for each well 
were balanced by adding vector pcDNA3. Data are mean ± SE of experiments performed in triplicate. 
*p < 0.01, and #p < 0.05 by ANOVA, compared with TRβ1 (+), T3 (+), and BDE209 (–) in A, B, and D and DE-71 (–) in G. 
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protein–DNA binding buffer. After extensive 
washing, protein–DNA binding on beads was 
detected using anti-DIG antibody conjugated 
to alkaline phosphatase, which was then meas-
ured by a chemiluminescent reaction using a 
luminometer. The LCDPA was performed at 
least three times, and data represent the mean 
± SE of one experiment.
Primary culture. The animal experimen-
tation protocol was approved by the Animal 
Care and Experimentation Committee, 
Gunma University. Pregnant Wistar 
rats were purchased from Japan SLC, Inc. 
(Hamamatsu, Japan). Animals were treated 
humanely and with regard for alleviation of 
suffering. Newborn rats were decapitated 
under diethyl ether anesthesia on post  natal 
day 1. We followed the culture protocol 
described by Kimura-Kuroda et al. (2007). 
Briefly, cerebella were digested with 0.2 U/mL   
papain (Worthington, Lakewood, NJ, USA). 
Dissociated cells were then suspended in a 
serum-free medium without THs, plated at 
a density of 2.0 × 105 cells/0.2 mL in poly-
l-lysine–coated wells of chamber slides 
(8-mm-diameter wells, NUNC Lab-Tek; 
Nalge Nunc International, Rochester, NY, 
USA), and cultured overnight in a 5% CO2 
incubator. Then, T4 and/or PBDEs were 
added to the culture medium. Half of the 
medium was replaced with fresh medium 
every 3–4 days, and cells were cultured for 
17 days. The pH of the culture medium was 
not altered after PBDE treatment. For TH 
treatment, T4 was used in primary culture 
because, physiologically, it is preferentially 
transported to brain through the blood–
brain barrier, and primary culture contains 
the whole subset of cerebellar cells, including 
astrocytes. Physiologically, T4 is taken up by 
astrocytes and deiodinated to T3, which is 
then transferred to neurons.
Immunocytochemistry for calbindin to 
analyze Purkinje cell development. Immuno-
cyto  chemistry of the cultured cells was 
described previously by Kimura-Kuroda 
et al. (2007). Briefly, we used a mouse mono-
clonal anti-calbindin-28K antibody (1:1,000; 
McAB 300; Swant, Bellinzona, Switzerland) 
and fluo  rescein isothio  cyanate (FITC)-
labeled donkey anti-mouse antibody (1:200; 
Molecular Probes, Eugene, OR, USA). 
The morphological changes were examined 
under a laser confocal scanning microscope 
(FV1000D spectral-type inverted IX81 micro-
scope; Olympus, Tokyo, Japan). To quan-
tify dendrite arborization, we manually traced 
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Figure 2. Effects of PBDE congeners (A) or OH-PBDEs and a PBDE mixture (B) 
on TR-mediated transcription and TR–TRE binding. Transient transfection-
based reporter gene assays (Figure 1A) and LCDPA (Figure 3E) were carried 
out using each chemical. Results of minimum effective dose, maximum sup-
pression (%) and dose, and maximum dissociation (%) and dose are listed. —, 
no effect.
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the outline of the cell and dendritic branches 
of 10 randomly selected Purkinje cells from 
each experi  ment, and the area was computed 
using NIH Image software (Vischer 2006). 
Data shown represent mean ± SE of one 
experiment. We performed more than three 
independent experiments and confirmed con-
sistency of the results. 
Statistical analysis. We analyzed treatment 
effects using analysis of variance (ANOVA). 
Post hoc comparison was made using 
Bonferroni’s test, and p-values < 0.05 are con-
sidered significant.
Results
Congener-specific suppression of TR-mediated 
transcription by PBDEs/OH-PBDEs. We 
examined the effect of various PBDE con-
geners, OH-PBDE metabolites, and PBDE 
mixtures on TR-mediated transcription in 
fibroblast-derived CV-1 cells using the tran-
sient transfection-based reporter gene assay. 
Representative results are shown in Figure 1 
[see also Supplemental Material, Figures 3 
and 4 (doi:10.1289/ehp.1002065)]. The tested 
compounds are listed in Figure 2. Among 
the PBDE compounds used, we observed 
the greatest magnitude of suppression with 
BDE209 and BDE100 (45% at 10–9 M; 
Figures 1A and 2A). BDE209 had the lowest 
effective dose (10–11 M) of the compounds 
evaluated (Figures 1A and 2). BDE209 sup-
pressed TRβ1-mediated transcription on 
F2-TRE and DR4-TRE but not on Pal-TRE 
(Figure 1A–C). PBDEs/OH-PBDEs did not 
alter transcription levels when TH was absent 
(Figure 1). BDE209 also suppressed TRα1-
mediated transcription (Figure 1D), but the 
magnitude of suppression was less than that 
for TRβ1-mediated transcription (Figure 1A). 
Figure 3. The effect of PBDE on TR cofactor or TR–TRE binding. (A) Schematic diagram of Gal4–SRC-1–NBD-1. Functionally active LXXLL motifs (Leu-Xaa-Xaa-
Leu-Leu) are located in central (residues 633–637, 690–694, and 749–753) and C-terminal (residues 1434–1438) regions termed NBD-1 and NBD-2, respectively. 
Gal4–SRC-1–NBD-1 contains amino acid residues 595–780 of SRC-1. (B) BDE209 did not affect SRC-1 binding to liganded TR in CV-1 cells. Expression plasmids 
encoding Gal4–DBD–fused SRC-1–NBD-1 (10 ng) were cotransfected with VP16 constructs (50 ng) and 5× UAS-TK-LUC reporter plasmids (170 ng) into CV-1 cells. 
Cells were incubated with or without T3 (10–7 M) and indicated concentrations of BDE209. (C) Schematic diagram of Gal4–N-CoR, which contains amino acid 
residues 1579–2454 of N-CoR. (D) BDE209 did not recruit N-CoR to TR in CV-1 cells. Expression plasmids harboring Gal4-DBD-fused N-CoR (100 ng) were cotrans-
fected with VP16-TRβ1-LBD (50 ng) and 5× UAS-TK-LUC (100 ng) into CV-1 cells. Cells were incubated with or without T3 (10–7 M) and indicated concentrations 
of BDE209. (E) Schematic diagram showing the LCDPA method. GST-TRβ1 bound to Sepharose beads was incubated with DIG-labeled F2-TRE in protein–DNA 
binding buffer with or without T3 (10–6 M) and indicated concentrations of PBDE. (F) The effect of BDE209 on TRβ1–TRE binding using LCDPA. In B, D, and F, data 
represent mean ± SE of experiments performed in triplicate. 
*p < 0.01 by ANOVA, compared with GST-TRβ1 (+), T3 (+), and PBDE (–).
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Several congeners (e.g., BDE47) did not sup-
press TR action (Figure 1E). We also exam-
ined the effect of hydroxylated metabolites, 
because several OH-PCBs suppressed TR 
action with a greater magnitude than did 
their parent PCBs (Miyazaki et al. 2004). 
However, as shown in Figures 1F and 2B 
[see also Supplemental Material, Figure 4D,E 
(doi:10.1289/ehp.1002065)], no OH-PBDEs 
suppressed TR action. DE-71, a commercial 
PBDE mixture, suppressed TR-mediated tran-
scription to some extent (Figures 1G and 2B), 
although BDE100 and BDE153 make up 
< 15% of the mixture. Trypan blue exclusion 
confirmed that the PBDEs/OH-PBDEs did 
not induce cell death under the concentrations 
used in this study (data not shown). Also, we 
examined the effect of PBDEs/OH-PBDEs 
on reporter vector expression without TR 
transfection and observed no significant 
change (data not shown). On the other hand, 
BDE209 did not suppress GR-mediated tran-
scription (Figure 1H), suggesting that the sup-
pressive effects may be TR specific.
PBDEs did not alter ligand-dependent 
cofactor recruitment to TRβ1 in CV-1 cells. We 
investigated the effect of PBDEs on binding 
between TR and coactivator using the mam-
malian two-hybrid assay with Gal4–SRC-1– 
NBD-1 and VP16-TRβ1-LBD (Figure 3A). 
Transcriptional activation by Gal4–SRC-1–
NBD-1 and VP16-TRβ1-LBD with T3 was 
not affected by BDE209 or any other com-
pounds used in the present study (Figure 3B), 
indicating that these compounds do not   
dissociate TR–coactivator binding.
Another possibility of PBDE action may 
be recruitment of corepressor complexes to 
liganded TR. Thus, we performed a mam-
malian two-hybrid assay using Gal4–N-CoR 
(Figure 3C) or Gal4-SMRT [see Supplemental 
Material, Figure 1A (doi:10.1289/ehp. 
1002065)], and VP16-TRβ1. Without T3, 
Gal4–N-CoR and VP16-TRβ1 activated tran-
scription (Figure 3D), whereas we observed 
no activation with T3. Activation was not 
altered by BDE209 or any other compounds 
used in the present study (Figure 3D). PBDEs 
also did not recruit SMRT without T3 (see 
Supplemental Material, Figure 1B). These 
results indicate that PBDEs do not recruit 
corepressors to TR.
PBDEs partially dissociate TR from TRE. 
To examine whether PBDEs dissociate TR 
from TRE in vitro, we performed LCDPA 
(Figure 3E). BDE209 (10–9 M) partially dis-
sociated TR from TRE (40%) in the presence 
of T3 (10–6 M; Figure 3F). Together with 
mammalian two-hybrid studies, these results 
indicate that the suppression of TR-mediated 
transcription by BDE209 was due to par-
tial dissociation of TR from TRE. On the 
other hand, BDE47, which did not suppress 
TR-mediated transcription, did not dissociate 
TR from TRE [see Supplemental Material, 
Figure 2 (doi:10.1289/ehp.1002065)]. 
However, BDE153, which suppresses 
TR-mediated transcription with a higher dose 
(10–8 M) than other compounds, did not dis-
sociate TR–TRE binding, although BDE153 
did not alter TR–cofactor binding either (data 
not shown). The results of LCDPA are sum-
marized in Figure 2.
TR-DBD may be responsible for the effect 
of PBDEs on TR action. Next, we attempted to 
identify the functional domains of TR respon-
sible for PBDE action using chimeric receptors 
(Figure 4A). Although all chimeric receptors 
harboring TR-DBD show suppression of tran-
scription by BDE209 regardless of the dif-
ference in LBD (Figure 4B,D), we observed 
no such suppression with receptors harboring 
DBD of GR (Figure 4C,E), indicating that the 
site of PBDE action may be DBD of TR.
PBDEs disrupt TH-dependent dendrite 
arborization of cerebellar Purkinje cells. We 
studied the effect of several PBDE/OH-PBDE 
compounds on T4-induced dendrite arboriza-
tion of cerebellar Purkinje cells in primary 
culture. Seventeen days after the onset of 
culture, cells were fixed and immuno  stained 
with anti-calbindin antibody. Addition of 
BDE209 (10–10 M) to the culture together 
with T4 inhibited development of Purkinje 
cell dendrites. The dendrites showed very 
poor growth, and the secondary branches 
were especially small (Figure 5A); the area of 
these Purkinje cell dendrites was signifi  cantly 
reduced (Figure 5A,C). In the absence of T4, 
BDE209-treated Purkinje cells showed almost 
complete absence of dendrites (Figure 5A). 
On the other hand, addition of BDE47 
(10–10 M), which does not suppress TR 
action, did not inhibit Purkinje cell dendrite 
develop  ment (Figure 5B). The dendritic area 
was not different from that without BDE47 
(Figure 5D). These data indicate that the 
PBDE congener that suppresses TR-mediated 
transcription also inhibits TH-mediated 
Purkinje cell dendrite arborization.
Figure 4. TR-mediated transcription is altered by PBDE through TR-DBD. (A) Schematic diagram 
of chimeric protein used in the present study. Abbreviations: G, GR; T, TR; N, N-terminal domain. 
(B,C) Representative examples of PBDE actions on chimeric receptor-induced transcription (B, GTG; 
C, TGT). (D,E) Effects of BDE209 on transcription through chimeric receptors containing TR-DBD (D) or 
GR-DBD (E). For B–E, chimeric receptors (10 ng) were cotransfected with F2-TRE (B,D) or MMTV (GRE)-
LUC (C,E) reporter plasmid (100 ng) into CV-1 cells and incubated with or without Dex (10–7 M) or T3 (10–7 
M; C), and 10–14 to 10–9 M BDE209. Data represent mean ± SE of experiments performed in triplicate. 
*p < 0.01, and #p < 0.05 by ANOVA, compared with GTG (+), Dex (+), and BDE209 (–) in B, and compared with chimeric 
receptors (+), ligand (+), and BDE209 (–) in D.
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Increasing the concentration of T4 could 
not fully rescue the suppression of T4-mediated 
Purkinje cell dendrite arborization by PBDEs. 
When we increased the T4 concentration to 
investigate the change in PBDE-mediated 
suppression of Purkinje cell dendrite arboriza-
tion, increasing amounts of T4 significantly 
ameliorated the effect of 10–10 M BDE209. 
However, even at 10–6 M, T4 could not fully 
rescue the suppression (Figure 6). Purkinje 
cells had fewer secondary branches and bifur-
cations and less dendrite area than those 
cultured with 10–8 M T4 alone (Figure 6), 
indicating that T4 can only partially rescue 
BDE209 action.
Discussion
In the present study, PBDE induced congener-
specific suppression of TR-mediated transcrip-
tion. Of the congeners evaluated, BDE209 
(deca-BDE) and BDE100 showed the greatest 
suppression (45% at 10–9 M), and BDE209 
had the lowest effective dose (10–11 M). Such 
effects may be partially induced by dis  socia  tion 
of TR from TRE. The site of PBDE action 
may be on TR-DBD. Furthermore, PBDE 
disrupted Purkinje cell dendrite arborization.
Because of structural similarity, we ini-
tially hypothesized that the suppression of 
TR-mediated transcription by PBDEs could 
be due to competitive inhibition of T3 binding 
to TR or alteration of TR–cofactor binding. 
However, the mechanism of action is com-
pletely different from our initial hypothe  sis. 
Our experiments, involving the mamma-
lian two-hybrid assay, transient transfection 
assays using chimeric receptors, and LCDPA, 
clearly demon  strated that the mechanism of 
action of PBDEs is similar to that of PCBs 
that we previously reported (Miyazaki et al. 
2008). However, the BDE153 congener 
did not cause dis  socia  tion of the binding by 
LCDPA, although it significantly suppressed 
TR action. It should be noted that BDE153 
did not alter TR–cofactor binding (data not 
shown). Because a greater amount of BDE153 
(10–8 M) is required to induce suppression in 
CV-1 cells, its effect may be too weak to detect 
by in vitro assay.
In the chimeric receptor experiments, 
all chimeric receptors containing TR-DBD 
showed suppression of transcription by 
PBDE regardless of the difference in N- or 
C-terminus (Figure 4B,D), whereas no such 
suppression was observed with receptors 
harboring GR-DBD (Figure 4C,E), indicat-
ing that the site of BDE209 action may be 
TR-DBD. These findings are similar to those 
of our previous studies showing that PCBs 
may disrupt TR action by partial dissociation 
of TR–TRE binding, acting via TR-DBD 
(Miyazaki et al. 2008). Thus, PBDEs and 
PCBs could affect TR-mediated gene expres-
sion via a common pathway. PBDEs and 
PCBs have also been shown to affect signal 
transduction pathways, particularly calcium 
Figure 5. Effect of PBDEs on dendrite arborization of Purkinje cell (17 days in culture). (A,B) Photomicrographs showing the effect of PBDEs on Purkinje cell mor-
phology. BDE209 (10–10 M; A) or BDE47 (10–10 M; B) was added to the culture in the absence or presence of T4 (10–8 M), and immunocytochemistry was performed 
using anti-calbindin antibody to visualize Purkinje cells. Bars = 50 μm. (C,D) Change in dendritic areas of Purkinje cells by BDE209 (C)or BDE47 (D). In C and D, data 
are expressed as mean ± SE (n = 10 determinations) from one experiment and represent at least three independent experiments. 
*p < 0.01 by ANOVA, for T4 (+)/BDE209 (–) compared with T4 (–)/BDE209 (–). #p < 0.01 by ANOVA, for T4 (+)/BDE209 (+) compared with T4 (+)/BDE209 (–).
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homeo  stasis and protein kinase C activ-
ity (Kodavanti and Ward 2005; Madia et al. 
2004). In contrast, although hydroxylated 
PCB metabolites have been shown to effec-
tively suppress TR-mediated gene expression 
(Miyazaki et al. 2008), the present study 
clearly revealed that only parent PBDE con-
geners effectively suppressed TR-mediated 
transcription. Thus, the site of PBDE action 
in the TR-DBD molecule could be different 
from that of PCBs because of differences in 
molecular structure and hydrophilicity. None 
of the OH-PBDE congeners used in our 
study significantly suppressed TR-mediated 
transcription (Figure 2B), although previous 
reports have suggested that other OH-PBDE 
congeners, whose concentration in humans 
is much lower, bound to TR (Kitamura et al. 
2008; Qiu X et al. 2009). Recently, Li et al. 
(2010) showed binding between TRβ1 and 
some OH-PBDE compounds used in our 
study. However, they failed to show tran-
scriptional activation or suppression with 
such compounds. Similar tendencies have 
been reported, showing that some OH-PBDE 
compounds—at low doses used in the present 
study—bind to TR without altering tran-
scriptional activities (Kitamura et al. 2008; 
Kojima et al. 2009). 
Although TH markedly promoted Purkinje 
cell dendrite arborization, BDE209 inhibited 
TH-induced dendrite development of Purkinje 
cells (Figure 5A,C). The effective dose, 10–10 M, 
is similar to that observed in our reporter gene 
assay. TRs are ubiquitously expressed in most 
cerebellar cells, including Purkinje cells, during 
development (Bradley et al. 1992), and previous 
studies have shown that TH induces Purkinje 
cell dendrite develop  ment via TR (Bradley et al. 
1992; Strait et al. 1991). Thus, the inhibitory 
effects of PBDEs observed in our study could 
be due to their action on TR-mediated gene 
expression in Purkinje cells and may conse-
quently disrupt normal brain development. 
However, increased concentrations of TH 
could not fully reverse the suppressive effects of 
BDE209 on TH-mediated Purkinje cell den-
drite arborization (Figure 6). Purkinje cells cul-
tured in the presence of 10–10 M BDE209 and 
10–7 M or 10–6 M T4 showed less arborized 
dendrites than did those cultured in the pres-
ence of 10–8 M T4 alone (Figure 6), indicating 
the existence of additional pathways, such as 
disruption of intra  cellular signaling pathways 
that rely on Ca2+ homeo  stasis (Dingemans et al. 
2010; Kodavanti and Ward 2005; Londoño 
et al. 2010; Madia et al. 2004) or induction of 
cytochrome P450 activities (Zhou et al. 2002). 
Further studies are required to investigate the 
synergistic effect of PBDEs on multiple sig-
nal trans  duction pathways. Nevertheless, the 
present study has provided an important clue 
to clarify the mechanisms of PBDE action in 
developing brain.
Because TH also tightly regulates fun-
damental gene expression both directly 
and indirectly, not only in the cerebellum 
but also in other brain regions (Koibuchi 
et al. 1999, 2001), the inhibitory effects of 
PBDEs on TR-mediated gene expression may 
widely disrupt normal brain development 
via TH-dependent gene regulations. Because 
PBDEs can be transferred to the developing 
brain through placenta or breast milk, con-
tinuous investigation is absolutely required 
for further clarification of PBDE action in 
other brain regions.
Conclusions
Our study shows that several PBDE congeners 
suppress TR-mediated gene expression by par-
tial dissociation of TR from TRE through the 
DBD. At least partly through such a mecha-
nism, PBDEs may inhibit TH-dependent 
dendrite arborization of cerebellar Purkinje 
cells. We hope that our study will provide 
significant clarifications on the mechanisms of 
PBDE action in the developing brain.
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